retatrutide while breastfeeding Is Right for You? Understanding the Eligibility Criteria Retatrutide: The triple-action peptide revolutionizing
Description
Consistent findings have shown that GLP-1R agonism promotes weight loss and improves glucose homeostasis in rodents, monkeys and humans (reviewed in Barrera et al., The anatomical distribution of the endogenous GLP-1 system GLP-1 is derived from the preproglucagon gene
Furthermore, patients treated with the dual GLP-1R and GIP agonist tirzepatide exhibited lower Food Craving Inventory scores for sweets and high-fat fast foods compared to those receiving liraglutide, indicating a greater reduction in desire for these items during weight loss (Martin et al., 2025)
Glucagon-like peptide-1 (GLP-1) is an incretin secretory molecule
At our CT clinic, we offer a variety of advanced weight loss injections, including GLP-1, GLP-1/GIP and Triple G combined with weekly visits and coaching
No causal link has been established in humans for retatrutide or other GLP-1-based medicines
For background on peptide research generally, see our comprehensive peptide guide for researchers
